Imagin Medical Inc. is a specialized medical technology company focused on developing advanced imaging and treatment solutions for urologic cancers, particularly prostate and bladder cancer. Its flagship products include the enCAGE Coil, a precision ablation device designed to minimize common post-treatment side effects such as erectile dysfunction and urinary incontinence, and the i/Blue Imaging System, which utilizes proprietary optics and light sensors to enhance the visualization of cancerous tissue during minimally invasive procedures. The i/Blue Imaging System aims to increase the efficiency and accuracy of bladder cancer detection, with side-by-side white and blue light display that supports real-time surgical decision-making. Imagin Medical targets healthcare providers and cancer care institutions, aiming to improve both patient outcomes and procedural efficacy. Managed by experienced medical device entrepreneurs, the company has made significant strides toward commercial deployment, including progress on regulatory approvals and product validation. It plays a notable role in the medical device sector by seeking to set new standards for cancer visualization and targeted intervention, ultimately striving to reduce recurrence rates and improve quality of life for patients undergoing cancer surgery.